Cited by 960Cancer-related Molecular PathwaysCancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.

p53 and metabolism

Vousden, Karen H., Ryan, Kevin M.·2009·Nature Reviews Cancer

Open this paper in CoChat — free account

Abstract

Although metabolic alterations have been observed in cancer for almost a century, only recently have the mechanisms underlying these changes been identified and the importance of metabolic transformation realized. p53 has been shown to respond to metabolic changes and to influence metabolic pathways through several mechanisms. The contributions of these activities to tumour suppression are complex and potentially rather surprising: some reflect the function of basal p53 levels that do not require overt activation and others might even promote, rather than inhibit, tumour progression.

Integrity signals

Registry

Crossref · 10.1038/nrc2715

Cites

134 of 134 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Tissue-specific Autophagy Alterations and Increased Tumorigenesis in Mice Deficient in Atg4C/Autophagin-3
Mariño, G., Salvador-Montoliu, N., Fueyo, A., Knecht, E., Mizushima, N., & López-Otı́n, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701194200 · Cited by 427
Retracted
On the origin of cancer cells
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., & Thompson, C. B. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.002 · Cited by 4,088
Development by Self-Digestion
Levine, B., & Klionsky, D. J. (2004) · Developmental Cell · doi:10.1016/s1534-5807(04)00099-1 · Cited by 3,728
Blinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
Self-citation
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Cancer cell metabolism: warburg and beyond
Hsu, P. P., & Sabatini, D. M. (2008) · Cell · doi:10.1016/j.cell.2008.08.021 · Cited by 2,452
p53 in health and disease
Vousden, K. H., & Lane, D. P. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2147 · Cited by 2,351
Self-citation

Flagged first, then by citations

Show all 134 references

Sorted by citations

Items 101–200 of 960

Roles of microRNA on cancer cell metabolism
Chen, B., Li, H., Zeng, X., Yang, P., Liu, X., Zhao, X., & Liang, S. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-228 · Cited by 206
A metabolic remodeling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension
Sutendra, G., Dromparis, P., Paulin, R., Zervopoulos, S. D., Haromy, A., Nagendran, J., & Michelakis, E. D. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1059-4 · Cited by 209
Stress-Responsive Sestrins Link p53 with Redox Regulation and Mammalian Target of Rapamycin Signaling
Budanov, A. V. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3530 · Cited by 208
The cancer theory of pulmonary arterial hypertension
Boucherat, O., Vitry, G., Trinh, I., Paulin, R., Provencher, S., & Bonnet, S. (2017) · Pulmonary Circulation · doi:10.1177/2045893217701438 · Cited by 211
Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53
Jing, K., Song, K., Shin, S., Kim, N., Jeong, S., Oh, H.-R., Park, J.-H., Seo, K.-S., Heo, J. Y., Han, J., et al. (2011) · Autophagy · doi:10.4161/auto.7.11.16658 · Cited by 208
Sugar-free approaches to cancer cell killing
Mjiyad, N. E., Caro‐Maldonado, A., Ramírez‐Peinado, S., & Muñoz‐Pinedo, C. (2010) · Oncogene · doi:10.1038/onc.2010.466 · Cited by 198
Positive regulation of p53 stability and activity by the deubiquitinating enzyme Otubain 1
Sun, X., Challagundla, K. B., & Dai, M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.434 · Cited by 195
TIGAR Is Required for Efficient Intestinal Regeneration and Tumorigenesis
Cheung, E. C., Athineos, D., Lee, P., Ridgway, R. A., Lambie, W., Nixon, C., Strathdee, D., Blyth, K., Sansom, O. J., & Vousden, K. H. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.05.001 · Cited by 192
Self-citation
The Metabolic Mechanisms of Breast Cancer Metastasis
Wang, L., Zhang, S., & Wang, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.602416 · Cited by 200
The Warburg Effect Revisited—Lesson from the Sertoli Cell
Oliveira, P. F., Martins, A. D., Moreira, A. C., Cheng, C. Y., & Alves, M. G. (2014) · Medicinal Research Reviews · doi:10.1002/med.21325 · Cited by 193
p53-Induced Adipose Tissue Inflammation Is Critically Involved in the Development of Insulin Resistance in Heart Failure
Shimizu, I., Yoshida, Y., Katsuno, T., Tateno, K., Okada, S., Moriya, J., Yokoyama, M., Nojima, A., Ito, T. K., Zechner, R., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.006 · Cited by 192
Targeting Metabolic Remodeling in Glioblastoma Multiforme
Wolf, A., Agnihotri, S., & Guha, A. (2010) · Oncotarget · doi:10.18632/oncotarget.190 · Cited by 194
Molecular and cellular pathways contributing to brain aging
Zia, A., Pourbagher‐Shahri, A. M., Farkhondeh, T., & Samarghandian, S. (2021) · Behavioral and Brain Functions · doi:10.1186/s12993-021-00179-9 · Cited by 195
Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer
Sutendra, G., Dromparis, P., Kinnaird, A. S., Stenson, T. H., Haromy, A., Parker, J. M. R., McMurtry, M. S., & Michelakis, E. D. (2012) · Oncogene · doi:10.1038/onc.2012.198 · Cited by 189
p53 regulates Period2 expression and the circadian clock
Miki, T., Matsumoto, T., Zhao, Z., & Lee, C. C. (2013) · Nature Communications · doi:10.1038/ncomms3444 · Cited by 195
Classification of lung cancer histology by gold nanoparticle sensors
Barash, O., Peled, N., Tisch, U., Bunn, P. A., Hirsch, F. R., & Haick, H. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.10.001 · Cited by 189
Harnessing metabolic dependencies in pancreatic cancers
Encarnación-Rosado, J., & Kimmelman, A. C. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00431-7 · Cited by 190
The role of the p53 tumor suppressor in metabolism and diabetes
Kung, C.-P., & Murphy, M. E. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0324 · Cited by 186
Targeting Mitochondrial Complex I Overcomes Chemoresistance in High OXPHOS Pancreatic Cancer
Masoud, R., Reyes-Castellanos, G., Lac, S., Garcia, J., Dou, S., Shintu, L., Abdel Hadi, N., Gicquel, T., El Kaoutari, A., Diémé, B., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100143 · Cited by 175
Metabolic changes in cancer: beyond the Warburg effect
Wu, W., & Zhao, S. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms104 · Cited by 173
p53-Mediated Molecular Control of Autophagy in Tumor Cells
Mrakovcic, M., & Fröhlich, L. F. (2018) · Biomolecules · doi:10.3390/biom8020014 · Cited by 170
Glucose Metabolism and Glucose Transporters in Breast Cancer
Shin, E., & Koo, J. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.728759 · Cited by 172
p53 and mitochondrial function in neurons
Wang, D. B., Kinoshita, C., Kinoshita, Y., & Morrison, R. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.015 · Cited by 174
Effect of atmospheric gas plasmas on cancer cell signaling
Ishaq, M., Evans, M. D. M., & Ostrikov, K. (2013) · International Journal of Cancer · doi:10.1002/ijc.28323 · Cited by 169
Control of skeletal muscle atrophy in response to disuse: clinical/preclinical contentions and fallacies of evidence
Atherton, P. J., Greenhaff, P. L., Phillips, S. M., Bodine, S. C., Adams, C. M., & Lang, C. H. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2016 · Cited by 180
On metabolic shift to lactate consumption in fed-batch culture of mammalian cells
Mulukutla, B. C., Gramer, M. J., & Hu, W. (2012) · Metabolic Engineering · doi:10.1016/j.ymben.2011.12.006 · Cited by 172
PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
Sen, N., Satija, Y. K., & Das, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.044 · Cited by 168
Reactive Oxygen Species Induced p53 Activation: DNA Damage, Redox Signaling, or Both?
Shi, T., & Dansen, T. B. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8074 · Cited by 173
No oxygen? No problem! Intrinsic brain tolerance to hypoxia in vertebrates
Larson, J., Drew, K. L., Folkow, L. P., Milton, S., & Park, T. J. (2014) · Journal of Experimental Biology · doi:10.1242/jeb.085381 · Cited by 163
Targeting cancer metabolism – aiming at a tumour's sweet-spot
Jones, N. P., & Schulze, A. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.12.017 · Cited by 164
The Central Sirtuin 1/p53 Pathway Is Essential for the Orexigenic Action of Ghrelin
Velásquez, D. A., Martínez, G., Romero, A., Vázquez, M. J., Boit, K. D., Dopeso-Reyes, I. G., López, M., Vidal, A., Nogueiras, R., & Diéguez, C. (2011) · Diabetes · doi:10.2337/db10-0802 · Cited by 161
CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway
Huang, Q., Li, J., Xing, J., Li, W., Li, H., Ke, X., Zhang, J., Ren, T., Shang, Y., Yang, H., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.04.035 · Cited by 159
DNA damaging agents and p53 do not cause senescence in quiescent cells, while consecutive re-activation of mTOR is associated with conversion to senescence
Leontieva, O. V., & Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100265 · Cited by 163
Sirt3 protects in vitro–fertilized mouse preimplantation embryos against oxidative stress–induced p53-mediated developmental arrest
Kawamura, Y., Uchijima, Y., Horike, N., Tonami, K., Nishiyama, K., Amano, T., Asano, T., Kurihara, Y., & Kurihara, H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42020 · Cited by 163
p53 is balancing development, differentiation and de-differentiation to assure cancer prevention
Molchadsky, A., Rivlin, N., Brosh, R., Rotter, V., & Sarig, R. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq101 · Cited by 161
Should mutant TP53 be targeted for cancer therapy?
Wang, Z., Strasser, A., & Kelly, G. L. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00962-9 · Cited by 162
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activityPreprint
Andrysík, Z., Galbraith, M. D., Guarnieri, A. L., Zaccara, S., Sullivan, K. D., Pandey, A., MacBeth, M. L., Inga, A., & Espinosa, J. M. (2017) · Genome Research · doi:10.1101/gr.220533.117 · Cited by 155
Therapeutics targeting p53-MDM2 interaction to induce cancer cell death
Koo, N., Sharma, A. K., & Narayan, S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095005 · Cited by 153
The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance
Biancur, D. E., & Kimmelman, A. C. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.04.011 · Cited by 152
Reduced carbohydrate availability enhances exercise-induced p53 signaling in human skeletal muscle: implications for mitochondrial biogenesis
Bartlett, J. D., Louhelainen, J., Iqbal, Z., Cochran, A. J., Gibala, M. J., Gregson, W., Close, G. L., Drust, B., & Morton, J. P. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00498.2012 · Cited by 147
Nuclear factor-κB, p53, and mitochondria: regulation of cellular metabolism and the Warburg effect
Johnson, R., & Perkins, N. D. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.04.002 · Cited by 149
The regulation of cellular metabolism by tumor suppressor p53
Liang, Y., Liu, J., & Feng, Z. (2013) · Cell & Bioscience · doi:10.1186/2045-3701-3-9 · Cited by 154
Regulation of Cellular Metabolism and Hypoxia by p53Preprint
Humpton, T. J., & Vousden, K. H. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026146 · Cited by 154
Self-citation
Glucose regulated protein 78: A critical link between tumor microenvironment and cancer hallmarks
Li, Z., & Li, Z. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.02.001 · Cited by 144
The Human TLR Innate Immune Gene Family Is Differentially Influenced by DNA Stress and p53 Status in Cancer Cells
Shatz, M., Menendez, D., & Resnick, M. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-4134 · Cited by 143
Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma
Rodríguez-Enríquez, S., Carreño-Fuentes, L., Gallardo-Pérez, J. C., Saavedra, E., Quezada, H., Vega, A., Marín-Hernández, A., Olín-Sandoval, V., Torres-Márquez, M. E., & Moreno-Sánchez, R. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.07.010 · Cited by 142
The antioxidant function of sestrins is mediated by promotion of autophagic degradation of Keap1 and Nrf2 activation and by inhibition of mTORC1
Rhee, S. G., & Bae, S. H. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.007 · Cited by 141
Degrons in cancer
Mészáros, B., Kumar, M., Gibson, T. J., Uyar, B., & Dosztányi, Z. (2017) · Science Signaling · doi:10.1126/scisignal.aak9982 · Cited by 147
Supercompetitor Status of Drosophila Myc Cells Requires p53 as a Fitness Sensor to Reprogram Metabolism and Promote Viability
de la Cova, C., Senoo‐Matsuda, N., Ziosi, M., Wu, D. C., Bellosta, P., Quinzii, C. M., & Johnston, L. A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.012 · Cited by 140
Identification of LDH-A as a therapeutic target for cancer cell killing via (i) p53/NAD(H)-dependent and (ii) p53-independent pathways
Allison, S. J., Knight, J. R. P., Granchi, C., Rani, R., Minutolo, F., Milner, J., & Phillips, R. M. (2014) · Oncogenesis · doi:10.1038/oncsis.2014.16 · Cited by 137
How theTP53Family ProteinsTP63andTP73Contribute to Tumorigenesis: Regulators and Effectors
Candi, E., Agostini, M., Melino, G., & Bernassola, F. (2014) · Human Mutation · doi:10.1002/humu.22523 · Cited by 137
Semaphorin3E-Induced Inflammation Contributes to Insulin Resistance in Dietary Obesity
Shimizu, I., Yoshida, Y., Moriya, J., Nojima, A., Uemura, A., Kobayashi, Y., & Minamino, T. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.001 · Cited by 144
p53 and glucose metabolism: an orchestra to be directed in cancer therapy
Gomes, A. S., Ramos, H., Soares, J., & Saraiva, L. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.015 · Cited by 143
Modulation of mitochondrial biogenesis and bioenergetic metabolism upon in vitro and in vivo differentiation of human ES and iPS cells
Prigione, A., & Adjaye, J. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103198ap · Cited by 138
Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer
Galluzzi, L., Vitale, I., Senovilla, L., Olaussen, K. A., Pinna, G., Eisenberg, T., Goubar, A., Martins, I., Michels, J., Kratassiouk, G., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.06.017 · Cited by 137
The Guardian of the Genome Revisited: p53 Downregulates Genes Required for Telomere Maintenance, DNA Repair, and Centromere Structure
Toufektchan, E., & Toledo, F. (2018) · Cancers · doi:10.3390/cancers10050135 · Cited by 144
Glucose metabolism in mammalian cell culture: new insights for tweaking vintage pathways
Mulukutla, B. C., Khan, S., Lange, A., & Hu, W.-S. (2010) · Trends in biotechnology · doi:10.1016/j.tibtech.2010.06.005 · Cited by 132
Small-Molecule Structure Correctors Target Abnormal Protein Structure and Function: Structure Corrector Rescue of Apolipoprotein E4–Associated Neuropathology: Miniperspective
Mahley, R. W., & Huang, Y. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3008618 · Cited by 132
Tumor‐suppressive micro RNA ‐143/145 cluster targets hexokinase‐2 in renal cell carcinoma
Yoshino, H., Enokida, H., Itesako, T., Kojima, S., Kinoshita, T., Tatarano, S., Chiyomaru, T., Nakagawa, M., & Seki, N. (2013) · Cancer Science · doi:10.1111/cas.12280 · Cited by 130
Regulation of glucose metabolism by p53: Emerging new roles for the tumor suppressor
Madan, E., Gogna, R., Bhatt, M. L. B., Pati, U., Kuppusamy, P., & Mahdi, A. A. (2011) · Oncotarget · doi:10.18632/oncotarget.389 · Cited by 137
Negative regulation of autophagy
Liang, C. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.115 · Cited by 132
Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells
Rasola, A., Neckers, L., & Picard, D. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.03.005 · Cited by 129
Tumor suppressor p53 and its gain-of-function mutants in cancer
Liu, J., Zhang, C., & Feng, Z. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt144 · Cited by 133
Principles of Exercise Prescription, and How They Influence Exercise-Induced Changes of Transcription Factors and Other Regulators of Mitochondrial Biogenesis
Granata, C., Jamnick, N. A., & Bishop, D. J. (2018) · Sports Medicine · doi:10.1007/s40279-018-0894-4 · Cited by 135
Colorectal Cancer and Metabolism
Brown, R. E., Short, S. P., & Williams, C. S. (2018) · Current Colorectal Cancer Reports · doi:10.1007/s11888-018-0420-y · Cited by 129
Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer
Werner, H. (2011) · Oncogene · doi:10.1038/onc.2011.447 · Cited by 128
The cytoplasmic side of p53's oncosuppressive activities
Comel, A., Sorrentino, G., Capaci, V., & Sal, G. D. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.015 · Cited by 130
Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms
Landor, S. K.-J., Mutvei, A. P., Mamaeva, V., Jin, S., Busk, M., Borra, R., Grönroos, T. J., Kronqvist, P., Lendahl, U., & Sahlgren, C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104943108 · Cited by 129
Particular phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice
Kılıç, Ü., Çağlayan, A. B., Beker, M. Ç., Günal, M. Y., Çağlayan, B., Yalçın, E., Keleştemur, T., Gundogdu, R. Z., Yuluğ, B., Yılmaz, B., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.04.006 · Cited by 126
Inhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53
Zawacka‐Pankau, J., Grinkevich, V. V., Hünten, S., Nikulenkov, F., Gluch, A., Li, H., Enge, M., Kel, A. E., & Selivanova, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240812 · Cited by 127
Ribosomal protein–Mdm2–p53 pathway coordinates nutrient stress with lipid metabolism by regulating MCD and promoting fatty acid oxidation
Liu, Y., He, Y. J., Jin, A., Tikunov, A. P., Zhou, L., Tollini, L. A., Leslie, P. L., Kim, T., Li, L. O., Coleman, R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315605111 · Cited by 131
Metabolic communication in tumors: a new layer of immunoregulation for immune evasion
Ho, P.-C., & Liu, P.-S. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0109-1 · Cited by 124
PD-L1 on invasive fibroblasts drives fibrosis in a humanized model of idiopathic pulmonary fibrosis
Geng, Y., Liu, X., Liang, J., Habiel, D. M., Kulur, V., Coelho, A. L., Deng, N., Xie, T., Wang, Y., Liu, N., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125326 · Cited by 127
Targeting mitochondria for cancer therapy
Hockenbery, D. M. (2010) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20552 · Cited by 124
Microenvironmental regulation of cancer cell metabolism: implications for experimental design and translational studies
Muir, A., Danai, L. V., & Heiden, M. G. V. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.035758 · Cited by 124
p53-mediated control of aspartate-asparagine homeostasis dictates LKB1 activity and modulates cell survival
Deng, L., Yao, P., Li, L., Ji, F., Zhao, S., Xu, C., Lan, X., & Jiang, P. (2020) · Nature Communications · doi:10.1038/s41467-020-15573-6 · Cited by 124
Fenofibrate Improves Renal Lipotoxicity through Activation of AMPK-PGC-1α in db/db Mice
Hong, Y. A., Lim, J. H., Kim, M. Y., Kim, T. W., Kim, Y., Yang, K. S., Park, H. S., Choi, S. R., Chung, S., Kim, H. W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096147 · Cited by 121
Aging: Molecular Pathways and Implications on the Cardiovascular System
de Almeida, A. J. P. O., Ribeiro, T. P., & de Medeiros, I. A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7941563 · Cited by 120
Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression
Uehara, I., & Tanaka, N. (2018) · Cancers · doi:10.3390/cancers10070219 · Cited by 117
The Molecular Mechanisms of Regulating Oxidative Stress-Induced Ferroptosis and Therapeutic Strategy in Tumors
Zhu, J., Xiong, Y., Zhang, Y., Wen, J., Cai, N., Cheng, K., Liang, H., & Zhang, W. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8810785 · Cited by 116
Dietary downregulation of mutant p53 levels via glucose restriction
Rodriguez, O. C., Choudhury, S., Kolukula, V. K., Vietsch, E. E., Catania, J., Preet, A., Reynoso, K., Bargonetti, J., Wellstein, A., Albanese, C., et al. (2012) · Cell Cycle · doi:10.4161/cc.22778 · Cited by 118
The roles of sirtuins family in cell metabolism during tumor development
Zhu, S., Dong, Z., Ke, X., Hou, J., Zhao, E., Zhang, K., Wang, F., Yang, L., Xiang, Z., & Cui, H. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.003 · Cited by 113
p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity
Molchadsky, A., Ezra, O., Amendola, P. G., Krantz, D., Kogan-Sakin, I., Buganim, Y., Rivlin, N., Goldfinger, N., Folgiero, V., Falcioni, R., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.9 · Cited by 117
Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model
Sanchez‐Macedo, N., Feng, J., Faubert, B., Chang, N., Elia, A., Rushing, E. J., Tsuchihara, K., Bungard, D., Berger, S. L., Jones, R. G., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2012.168 · Cited by 117
The role of mitochondria in pulmonary vascular remodeling
Dromparis, P., Sutendra, G., & Michelakis, E. D. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0670-x · Cited by 114
Gene Sets Net Correlations Analysis (GSNCA): a multivariate differential coexpression test for gene sets
Rahmatallah, Y., Emmert-Streib, F., & Glazko, G. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt687 · Cited by 110
Caspase-2: the orphan caspase
Bouchier‐Hayes, L., & Green, D. R. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.157 · Cited by 110
Nutrient-sensing mTORC1: Integration of metabolic and autophagic signals
Tan, V. P., & Miyamoto, S. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.01.005 · Cited by 113
The fine tuning of metabolism, autophagy and differentiation during in vitro myogenesis
Fortini, P., Ferretti, C., Iorio, E., Cagnin, M., Garribba, L., Pietraforte, D., Falchi, M., Pascucci, B., Baccarini, S., Morani, F., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.50 · Cited by 116
Tumor Suppressor p53 Alters Host Cell Metabolism to Limit Chlamydia trachomatis Infection
Siegl, C., Prusty, B. K., Rajeeve, K., Wischhusen, J., & Rudel, T. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.004 · Cited by 116
Lactic acidosis switches cancer cells from aerobic glycolysis back to dominant oxidative phosphorylation
Wu, H., Ying, M., & Hu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9746 · Cited by 114
p53 regulates glucose metabolism by miR-34a
Kim, H.-R., Roe, J., Lee, J., Cho, E., & Youn, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.043 · Cited by 115
Regulation of Cancer Metabolism by Oncogenes and Tumor Suppressors
Iurlaro, R., León‐Annicchiarico, C. L., & Muñoz‐Pinedo, C. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00003-0 · Cited by 114
The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction
Kung, C.-P., Leu, J. I.-J., Basu, S., Khaku, S., Anokye‐Danso, F., Liu, Q., George, D. L., Ahima, R. S., & Murphy, M. E. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.037 · Cited by 106
Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
Lambert, J. M. R., Moshfegh, A., Hainaut, P. L., Wiman, K. G., & Bykov, V. J. N. (2009) · Oncogene · doi:10.1038/onc.2009.425 · Cited by 111
Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high ROS levels
Kalo, E., Kogan-Sakin, I., Solomon, H., Natan, E. B., Shay, M., Shetzer, Y., Dekel, E., Goldfinger, N., Buganim, Y., Stambolsky, P., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.106815 · Cited by 107
High expression levels of pyrimidine metabolic rate–limiting enzymes are adverse prognostic factors in lung adenocarcinoma: a study based on The Cancer Genome Atlas and Gene Expression Omnibus datasets
Wang, H., Wang, X., Xu, L., Zhang, J., & Cao, H. (2020) · Purinergic Signalling · doi:10.1007/s11302-020-09711-4 · Cited by 104
Oncosuppressive Functions of Autophagy
Morselli, E., Galluzzi, L., Kepp, O., Mariño, G., Michaud, M., Vitale, I., Maiuri, M. C., & Kroemer, G. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3478 · Cited by 112
Immortalization of oral keratinocytes by functional inactivation of the p53 and pRb pathways
Smeets, S. J., van der Plas, M., Schaaij‐Visser, T. B. M., van Veen, E. A. M., van Meerloo, J., Braakhuis, B. J. M., Steenbergen, R. D. M., & Brakenhoff, R. H. (2010) · International Journal of Cancer · doi:10.1002/ijc.25474 · Cited by 104
The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells
Johannessen, T.-C. A., Prestegarden, L., Grudic, A., Hegi, M. E., Tysnes, B. B., & Bjerkvig, R. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos301 · Cited by 103

Authors: Vousden, K. H., & Ryan, K. M.
Affiliations: Cancer Research UK Scotland Institute (GB)
ORCID: Vousden, Karen H.
Ryan, Kevin M.
Venue: Nature Reviews Cancer
Publisher: Springer Science and Business Media LLC
Published: 2009-09-17
Volume: 9
Issue: 10
Pages: 691-700
ISSN: 1474-175X (ISSN-L)
1474-1768
DOI: 10.1038/nrc2715
OpenAlex: W1991510903
Cited by: 959
References: 134
Citations by year: 2026: 23 · 2025: 39 · 2024: 37 · 2023: 36 · 2022: 49 · 2021: 46 · 2020: 44 · 2019: 39 · 2018: 49 · 2017: 52 · 2016: 60 · 2015: 78 · 2014: 84 · 2013: 97 · 2012: 82
FWCI: 6.60
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Cancer (publishedVersion)
PubMed (publishedVersion)
ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
Funders: Cancer Research UK
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: p53, cancer metabolism, tumor suppression, tumor progression, metabolic pathways, cancer cells
MeSH terms: Autophagy, Cell Transformation, Neoplastic, Glycolysis, Humans, Neoplasms, Tumor Suppressor Protein p53, Oxidative Stress, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

p53 and metabolism

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks